Stock Upgrades: Arcturus Therapeutics Shows Rising Relative Strength

One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Arcturus Therapeutics (ARCT) now clears that threshold, with a jump from 79 to 82 Friday.


When you’re researching the best stocks to buy and watch, keep a close on eye on relative price strength.

This exclusive rating from Investor’s Business Daily identifies market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock’s price movement over the trailing 52 weeks compares to all the other stocks in our database.

History reveals that the market’s biggest winners often have an RS Rating north of 80 as they begin their biggest price moves.

See How IBD Helps You Make More Money In Stocks

While it’s not currently an ideal time to jump in, see if the stock goes on to form a base and break out.

Earnings growth declined in the most recent report from 0% to -276%. But revenue gains moved higher, from -20% to -14%. Look for the next report on or around Nov. 9.

Arcturus Therapeutics earns the No. 292 rank among its peers in the Medical-Biomed/Biotech industry group. Alkermes (ALKS) and Innoviva (INVA) are also among the group’s highest-rated stocks.


Biotech And Pharmaceutical Industry And Stock News

IBD Stock Rating Upgrades: Rising Relative Strength

Why Should You Use IBD’s Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

See How To Reduce Risk, Increase Profits With Swing Trading

Most Related Links :
newsbinding Governmental News Finance News

Source link

Back to top button